30Sep 2021
Alteration of Bone Density, Microarchitecture, and Strength in Patients with Camurati–Engelmann Disease: Assessed by HR‐pQCT

Alteration of Bone Density, Microarchitecture, and Strength in Patients with Camurati–Engelmann Disease: Assessed by HR‐pQCT

Camurati‐Engelmann disease (CED) is a rare autosomal‐dominant skeletal dysplasia caused by mutations in the transforming growth factor‐β1 (TGFB1) gene. HR‐pQCT results showed lower volumetric BMD (vBMD), altered bone microstructure and lower estimated bone strength at the distal radius and tibia in patients with CED compared with controls. In conclusion, HR‐pQCT was used to investigate bone microstructure at the distal radius and tibia in nine patients with CED, and the alteration of bone density, microstructure, and strength was shown for the first time.

  • #orthopaedics

Like

Save

Share